Pricing Log in Create free account

MindWalk Holdings Corp. (HYFT) vs Mereo BioPharma Group plc - Sponsored ADR (MREO)

MindWalk Holdings Corp. and Mereo BioPharma Group plc - Sponsored ADR are both Biotechnology companies. MindWalk Holdings Corp. and Mereo BioPharma Group plc - Sponsored ADR are of similar size ($47.1M and $44.8M). Mereo BioPharma Group plc - Sponsored ADR has the higher net margin (0.00% vs −105.1%) and the higher return on invested capital (0.00% vs −464.6%). Across the 14 metrics below, Mereo BioPharma Group plc - Sponsored ADR leads on 9 and MindWalk Holdings Corp. on 5.

Valuation

Metric HYFT MREO Biotechnology median
P/E n/m n/m 10.60
P/S 4.19 n/m 9.40
P/B 9.93 1.57 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 4.10 n/m 9.02
Earnings yield (24.76%) (62.36%) (32.88%)
Free cash flow yield (18.31%) (57.04%) (23.13%)

Profitability

Metric HYFT MREO Biotechnology median
Gross margin 60.81% 0.00% 68.51%
Operating margin (103.99%) 0.00% 0.00%
Net margin (105.06%) 0.00% 0.00%
Free cash flow margin (76.79%) 0.00% 0.00%
Return on equity (122.85%) (67.85%) (51.96%)
Return on assets (58.55%) (57.73%) (46.06%)
Return on invested capital (464.59%) 0.00% 0.00%

Growth

Metric HYFT MREO Biotechnology median
Revenue growth (TTM) (26.99%) — 6.76%
EPS growth (last fiscal year) 66.15% 10.16% 29.88%
Revenue growth, 5-year CAGR (3.83%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HYFT MREO Biotechnology median
Debt to equity 0.43 0.00 0.00
Current ratio 1.84 5.88 4.97
Net debt to EBITDA 0.62 1.04 1.01

Dividend

Metric HYFT MREO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric HYFT MREO Biotechnology median
Market cap 47.12m 44.76m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack